MEK162 for patients with advanced melanoma harbouring NRAS...

The Lancet Oncology 2013 / 03 Vol. 14; Iss. 3

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

Ascierto, Paolo A, Schadendorf, Dirk, Berking, Carola, Agarwala, Sanjiv S, van Herpen, Carla ML, Queirolo, Paola, Blank, Christian U, Hauschild, Axel, Beck, J Thaddeus, St-Pierre, Annie, Niazi, Faiz,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(13)70024-X
Date:
March, 2013
File:
PDF, 220 KB
english, 2013
Conversion to is in progress
Conversion to is failed